North America Wearables in Pharma & Biotech Market (2026-2031)
The North America Wearables in Pharma & Biotech Market was valued at $414.1 Million in 2026 and projected to reach to $991.3 Million by 2031, representing a compound annual growth rate of 19.1%. North America's wearables in pharma and biotech market is positioned for sustained growth through 2031, driven by technological advancements in biosensors, increasing investment in digital therapeutics, and growing collaboration between pharmaceutical companies and wearable device manufacturers.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Wearables in Pharma & Biotech Market Trends and Insights
- This growth trajectory reflects North America's leadership in digital health innovation, regulatory support, and increasing adoption of remote patient monitoring solutions across the region.
- North America's advanced healthcare infrastructure and strong investment in medical device technology are driving accelerated market penetration. The North America market benefits from high healthcare spending, favorable reimbursement policies, and a concentration of leading pharmaceutical and biotech companies investing in wearable-integrated clinical trials.
- North America's aging population and rising prevalence of chronic diseases are creating sustained demand for continuous monitoring devices.
- By 2031, North America is expected to maintain its position as a key growth engine, with wearable technologies becoming integral to drug development, patient engagement, and real-world evidence collection across the region..
Key Market Statistics
- CAGR (2026-2031) 19.1% CAGR
- Market Size, 2026 ~USD 414.1 Million
- Forecast, 2031 ~USD 991.3 Million
- Geography North America
North America Wearables in Pharma & Biotech Market Overview
Market Valuation & Growth :
North America's wearables in pharma and biotech market is valued at $414.1 million in 2026, with a robust CAGR of 19.1%, projected to reach $991.3 million by 2031, demonstrating strong regional momentum.
Digital Health Leadership :
North America leads globally in digital health innovation and remote patient monitoring adoption, driven by advanced healthcare infrastructure, FDA regulatory support, and high healthcare spending across the US and Canada.
Regulatory Environment :
Favorable regulatory frameworks in the US and Canada, including FDA clearances for wearable medical devices and reimbursement policies, accelerate market adoption and encourage pharmaceutical companies to integrate wearables into clinical trials.
Remote Patient Monitoring Expansion :
Increasing adoption of remote patient monitoring solutions across North America, driven by post-pandemic telehealth acceleration, chronic disease management needs, and integration of wearables into personalized medicine strategies.
North America Wearables in Pharma & Biotech Market Dynamics
- The region's mature healthcare ecosystem and strong reimbursement landscape support rapid adoption of continuous monitoring solutions for clinical trials and patient management. Key growth drivers include rising prevalence of chronic diseases, demand for real-world evidence in drug development, and integration of artificial intelligence with wearable data analytics.
- North American pharmaceutical companies are increasingly leveraging wearables for drug efficacy monitoring and adverse event detection, while regulatory bodies continue to streamline approval pathways for digital health solutions, further accelerating market expansion..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- North America's wearables in pharma & biotech market will grow from $414.1M (2026) to $991.3M (2031), representing a 19.1% CAGR.
- North America leads global adoption due to advanced healthcare infrastructure, strong regulatory frameworks, and high R&D investment by pharmaceutical companies.
- North America's market is driven by increasing clinical trial digitalization, remote patient monitoring demand, and real-world evidence collection initiatives.
- North America's competitive landscape features established medical device manufacturers and emerging digital health startups partnering with major pharma and biotech firms.
Wearables in Pharma & Biotech Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | MENTAL HEALTH & BEHAVIORAL HEALTH (Therapeutic Area) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 20.2% from 2026 to 2031 |
| Largest Segment | PHARMACEUTICAL & BIOTECH COMPANIES (End User) |
| Market Size Base Year (Billions) | ~USD 3.97 (2026) |
| Revenue Forecast (Billions) | ~USD 9.97 (2031) |
| Segments Covered | Product, Therapeutic Area, Type, Application, End User |
North America Wearables in Pharma & Biotech Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Continuous Glucose Monitors
- Fitness Bands
- Other Products
- Patches
- Smart Rings
- Smartwatches
- Wearable Injectors
By Therapeutic Area
- Cardiovascular
- Diabetes
- Lifestyle & Wellness Improvement
- Mental Health & Behavioral Health
- Musculoskeletal Disorders/Pain Management
- Neurology
- Oncology
- Other Diseases
- Respiratory Disorders
- Women’S Health & Reproductive Health
By Type
- Atherosclerotic Cardiovascular Diseases/Secondary Prevention
- Atrial Fibrillation/Stroke Prevention
- Brain Tumor
- Breast Cancer
- Colorectal Cancer
- Heart Failure
- Hematologic Malignancies
- Hypertension
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Myeloma
- Other Hematologic Malignancies
- Other Solid Tumors
- Phase Ii
- Phase Iii
- Phase Iv
- Prostate Cancer
- Pulmonary Hypertension
- Solid Tumors
- Structural Heart Diseases/Interventional Cardiology
By Application
- Chronic Disease Monitoring
- Clinical Trials
- Drug Discovery
- Medication Adherence & Behavioral Support
- Personalized & Preventive Digital Therapeutics
By End User
- Contract Research Organizations
- Healthcare Providers & Clinicians
- Other End Users
- Pharmaceutical & Biotech Companies
Target Audience
- Pharmaceutical Companies : North American pharma executives need regional market data to evaluate wearable integration in clinical trials, optimize patient monitoring strategies, and assess competitive positioning in digital health innovation.
- Biotech Firms : Biotech companies require North America-specific insights to develop wearable-enabled drug development platforms, secure funding for digital health initiatives, and navigate FDA regulatory pathways for device-drug combinations.
- Medical Device Manufacturers : Device makers targeting North American pharma partnerships need market sizing, growth forecasts, and customer requirements to develop wearables aligned with pharmaceutical and biotech sector demands.
- Healthcare Investors & PE Firms : Investment professionals evaluating North American digital health opportunities require regional market data, growth trajectories, and competitive analysis to identify high-potential wearables pharma investments.
- Healthcare Consultants & Analysts : Consulting firms and research analysts need comprehensive North America market intelligence to advise clients on wearables strategy, market entry, and competitive positioning in the pharma and biotech sectors.
Key Companies in the North America Wearables in Pharma & Biotech Market
| Company | HQ | Ownership | Strongest segments |
|---|
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 3973.4 Million |
| Canada | USD 235.21 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuations for North America ($414.1M in 2026, $991.3M in 2031) with country-level breakdowns for US and Canada, enabling accurate business planning and investment decisions specific to the region.
- Competitive Landscape Analysis : Understand North American market dynamics, key players, and competitive positioning in the wearables pharma sector, including regulatory advantages and market consolidation trends unique to the region.
- Regulatory & Reimbursement Insights : Access detailed analysis of FDA approval pathways, reimbursement policies, and regulatory frameworks driving wearable adoption in North American pharmaceutical and biotech companies' clinical operations.
- Strategic Growth Opportunities : Identify high-growth segments within North America's wearables market, including remote monitoring, digital therapeutics integration, and real-world evidence collection for drug development and post-market surveillance.
- Investment & Partnership Guidance : Leverage North America-specific market intelligence to guide M&A strategies, partnership development, and technology investments in the wearables pharma ecosystem across the US and Canadian markets.
Frequently asked questions
What is the current market size of wearables in pharma & biotech in North America?
North America's wearables in pharma and biotech market is valued at $414.1 million in 2026, with expectations to reach $991.3 million by 2031.
What is the projected growth rate for North America's wearables market?
North America's wearables in pharma and biotech market is expected to grow at a compound annual growth rate (CAGR) of 19.1% from 2026 to 2031.
What factors are driving growth in North America's wearables pharma market?
North America's market growth is driven by digital clinical trial adoption, remote patient monitoring expansion, favorable regulatory environments, and increased pharmaceutical company investment in real-world evidence collection.
Which segments dominate North America's wearables in pharma & biotech market?
North America's market is dominated by smartwatches, fitness trackers, and specialized medical wearables used in clinical trials, drug development, and chronic disease management applications.
How does North America compare to other regions in wearables adoption?
North America leads global markets due to its advanced healthcare infrastructure, high healthcare expenditure, strong regulatory support, and concentration of major pharmaceutical and biotech companies investing in wearable technologies.
RESEARCH METHODOLOGY
This study involved five major activities to estimate the current size of the wearables in pharma & biotech market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of the wearables in pharma & biotech market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global wearables in pharma & biotech market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
Note: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million. Other designations include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the wearables in pharma & biotech market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:
Wearables in Pharma & Biotech Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the wearables in pharma & biotech market.
Market Definition
The wearables in pharma & biotech market comprise sensor-based, body-worn, or minimally invasive devices and associated digital platforms used to capture continuous physiological and behavioral data across the drug development and healthcare continuum. This includes products such as smartwatches, fitness bands, smart rings, continuous glucose monitors (CGMs), wearable patches, and wearable injectors, which enable real-time monitoring of parameters like heart rate, glucose levels, activity, and treatment adherence. These technologies are applied across a wide range of therapeutic areas, including cardiovascular diseases, oncology (solid tumors and hematologic malignancies), diabetes, mental health, respiratory, neurological, musculoskeletal, and women’s health conditions. The market spans key applications, such as drug discovery, clinical trials (Phase II–IV), medication adherence, chronic disease monitoring, and personalized digital therapeutics, supporting decentralized trials and real-world evidence generation. End users primarily include pharmaceutical and biotechnology companies, healthcare providers, and research organizations, all leveraging wearable technologies to enable data-driven, patient-centric care and more efficient drug development.
Key Stakeholders
- Wearable device & biosensor manufacturers (smartwatches, CGMs, patches, smart rings, wearable injectors)
- Digital health & software platform providers (mobile apps, cloud platforms, AI analytics)
- Component, sensor, & semiconductor technology providers
- Pharmaceutical companies
- Biotechnology companies
- Contract research organizations (CROs)
- Clinical trial sponsors & site management organizations
- Healthcare providers (hospitals, clinics, remote patient monitoring programs)
- Patients & caregivers
- Payers & insurers
- Regulatory & public health authorities (e.g., US Food and Drug Administration, European Medicines Agency)
- Academic institutions & research organizations
- Data management, interoperability & cloud infrastructure providers
- Cybersecurity & data privacy solution providers
- System integrators & IT service providers
- Venture capital & private equity firms
- Investors & financial institutions
- Consulting, regulatory, & compliance service providers
Report Objectives
- To define, describe, and forecast the wearables in pharma & biotech market based on product, therapeutic area, application, end user, and region
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure profile of the key players and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, product approvals, and alliances in the market
Customization Options:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company.
Geographic Analysis
- Further breakdown of the Latin America, Europe, and the Middle East & Africa markets into specific countries
Get the Full Wearables in Pharma & Biotech Market Report
Full forecast, segment splits, and company analysis for all Wearables in Pharma & Biotech Market.
- US Wearables in Pharma & Biotech Market
- Canada Wearables in Pharma & Biotech Market
- Germany Wearables in Pharma & Biotech Market
- France Wearables in Pharma & Biotech Market
- UK Wearables in Pharma & Biotech Market
- Italy Wearables in Pharma & Biotech Market
- Spain Wearables in Pharma & Biotech Market
- China Wearables in Pharma & Biotech Market
- Japan Wearables in Pharma & Biotech Market
- India Wearables in Pharma & Biotech Market
- Australia Wearables in Pharma & Biotech Market
- South Korea Wearables in Pharma & Biotech Market
- Brazil Wearables in Pharma & Biotech Market
- Mexico Wearables in Pharma & Biotech Market
- Saudi Arabia Wearables in Pharma & Biotech Market
- UAE Wearables in Pharma & Biotech Market
- South Africa Wearables in Pharma & Biotech Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report